DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study explores the safety and efficacy of intravenous iron therapy in anemic
hemodialysis patients treated with epoetin alfa, who have higher serum ferritin levels, but
low to normal transferrin saturation.